Sickle Cell Thalassemia
Showing 1 - 25 of >10,000
Mitapivat in Subjects With Sickle Cell Disease
Enrolling by invitation
- Sickle Cell Anemia
- +7 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Pumilio1 Expression, Sickle Cell Anemia, ß-thalassemia
Not yet recruiting
- Sickle Cell Disease, Beta Thalassemia Intermedia
- RNA Binding Protein Pumilio1 (PUM1) Expression by reverse transcriptase quantatative PCR
- (no location specified)
May 30, 2023
Sickle Cell Anemia, Beta Thalassemia Trial run by the NHLBI (radiation, drug, biological)
Recruiting
- Sickle Cell Anemia
- Beta Thalassemia
- TBI
- +6 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Sickle Cell Disease, Sickle Cell Trait, Beta-Thalassemia Trial (High performance liquid chromatography, Automated sickling test,
Not yet recruiting
- Sickle Cell Disease
- +4 more
- High performance liquid chromatography
- +5 more
- (no location specified)
Aug 17, 2022
Sickle Cell Disease, Hb-SS Disease, Hemoglobin S Trial run by the National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting
- Sickle Cell Disease
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jun 21, 2023
Sickle Cell Disease, Thalassemia, Stem Cell Transplantation Trial run by the National Heart, Lung, and Blood Institute (NHLBI)
Recruiting
- Sickle Cell Disease
- +3 more
- Alemtuzumab
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Beta-Thalassemia, Thalassemia, Hematologic Diseases Trial (CTX001)
Not yet recruiting
- Beta-Thalassemia
- +6 more
- CTX001
- (no location specified)
Jul 26, 2022
Cancer, Sickle Cell Thalassemia, Hematologic Diseases Trial in Brussels (Autologous testicular tissue transplantation of
Recruiting
- Cancer
- +2 more
- Autologous testicular tissue transplantation of prepubertal frozen testicular tissue
-
Brussels, BelgiumUZ Brussel Centre for Reproductive Medicine
Jun 7, 2022
Sickle Cell Disease, Thalassemia, Beta, Thalassemia Trial in United States (Fludarabine, Cyclophosphamide, Tacrolimus)
Recruiting
- Sickle Cell Disease
- +2 more
- Fludarabine
- +7 more
-
Basking Ridge, New Jersey
- +5 more
Feb 17, 2023
Human Biospecimens for Basic and Clinical Research Into Globin
Recruiting
- Alpha and Beta Thalassemia
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
A Long-term Follow-up Study in Subjects Who Received CTX001
Enrolling by invitation
- Beta-Thalassemia
- +6 more
- CTX001
-
New York, New York
- +12 more
Nov 18, 2022
Sickle Cell-thalassemia Disease, Thalassemia Trial in Washington (peripheral blood stem cell graft that are CD34+ selected)
Active, not recruiting
- Sickle Cell-thalassemia Disease
- Thalassemia
- peripheral blood stem cell graft that are CD34+ selected
-
Washington, District of ColumbiaChildrens National Medical Center
Jul 15, 2021
Hemoglobinopathies, Thalassemia, Sickle Cell Disease Trial in Banha (Hemoglobinopathy Nursing Program)
Completed
- Hemoglobinopathies
- +3 more
- Hemoglobinopathy Nursing Program
-
Banhā, Other, EgyptBenha University
May 21, 2022
Sickle Cell Disease, Thalassemia Major Trial in Philadelphia (CliniMACS)
Recruiting
- Sickle Cell Disease
- Thalassemia Major
- CliniMACS
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Dec 22, 2021
Congenital Hemolytic Anemia, Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Peripheral
Recruiting
- Congenital Hemolytic Anemia
- Sickle Cell Disease
- Peripheral blood hematopoietic progenitor cell (PBPC) transplant
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Sickle Cell Anemia Trial run by the NHLBI (PBSC Transplant, Alemtuzumab, Sirolimus)
Active, not recruiting
- Sickle Cell Anemia
- PBSC Transplant
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 13, 2022
Sickle Cell Disease, Sickle Cell Disorder, Hemoglobinopathies Trial in Duarte (Cyclophosphamide, Pentostatin, Rabbit
Recruiting
- Sickle Cell Disease
- +4 more
- Cyclophosphamide
- +5 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jul 6, 2022
Sickle Cell Anemia, Beta-thalassemia Major, Diamond-blackfan Anemia Trial in Pittsburgh (CD3/CD19 depleted leukocytes, CD45RA
Recruiting
- Sickle Cell Anemia
- +2 more
- CD3/CD19 depleted leukocytes
- +6 more
-
Pittsburgh, PennsylvaniaChildren's Hospital of Pittsburgh of UPMC
May 4, 2022
Sickle Cell Disease, Sickle Beta Zero Thalassemia, Sickle B+ Thalassemia Trial in Chicago (MED-Go App)
Recruiting
- Sickle Cell Disease
- +3 more
- MED-Go App
-
Chicago, IllinoisAnn & Robert H Lurie Children's Hospital of Chicago
Mar 7, 2022
Sickle Cell Disease, Thalassemia Trial in Memphis (Hydroxyurea, Hydroxyurea Oral Capsule)
Terminated
- Sickle Cell Disease
- Thalassemia
- Hydroxyurea
- Hydroxyurea Oral Capsule
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Feb 18, 2022
Myeloid Chimerism Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (CliniMACS CD34 Reagent)
Recruiting
- Myeloid Chimerism
- CliniMACS CD34 Reagent
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Apr 7, 2022
Sickle Cell Disease and Thalassemia Trial in Dallas (Donor Stem Cell Transplantation)
Withdrawn
- Sickle Cell Disease and Thalassemia
- Donor Stem Cell Transplantation
-
Dallas, TexasUT Southwestern Medical Center
Jul 22, 2021